Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes.

Javier Caballero-VillarrasoJamil SawasBegoña M EscribanoFrancisco A Martín-HersogAndrea Valverde-MartínezIsaac Túnez

Published in: Expert review of neurotherapeutics (2021)

There is a class I evidence supporting the effectiveness of cell therapy as safe therapeutic option in multiple sclerosis with health benefits in the medium and long term.

Keyphrases

cell therapy
multiple sclerosis
systematic review
stem cells
mesenchymal stem cells
healthcare
white matter
meta analyses
public health
randomized controlled trial
mental health
genome wide
cancer therapy
social media
health information
drug delivery
replacement therapy
genome wide identification
data analysis